Bacterial overgrowth syndrome;Bakterielle fehlbesiedlung des dünndarms

Zeitschrift fur Gastroenterologie

Volumn 45, Issue 7, 2007, Pages 620-628

  Stein, Jürgen M ^a   Schneider, A R ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Bacterial overgrowth; Irritable colon; Malassimilation

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFALEXIN; CEPHALOSPORIN; CHLORTETRACYCLINE; CIPROFLOXACIN; CISAPRIDE; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; NORFLOXACIN; OCTREOTIDE; OMEPRAZOLE; PROKINETIC AGENT; RIFAMPICIN DERIVATIVE; RIFAXIMIN; TETRACYCLINE;

ANEMIA; BACTERIAL OVERGROWTH; CLINICAL TRIAL; DIARRHEA; DISEASE PREDISPOSITION; ENTERITIS; HUMAN; INTESTINE OBSTRUCTION; MALABSORPTION; NUTRITIONAL DEFICIENCY; PATHOPHYSIOLOGY; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; STEATORRHEA; STOMACH SECRETION; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BLIND LOOP SYNDROME; BREATH TESTS; DRUG THERAPY, COMBINATION; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; RISK FACTORS;

EID: 34547752399     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963045     Document Type: Review

References (103)

1. Abrahamsson H. Gastrointestinal motility in patients with the irritable bowel syndrome. Scand J Gastroenterol Suppl 1987; 130: 21-26
2. Almeida J, Galhenage S, Yu J et al. Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol 2006; 12: 1493-1502
3. Attar A, Flourie B, Rambaud JC et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomized trial. Gastroenterology 1999; 117: 794-799
4. Bardham FK, Gyr K, Beglinger C et al. Diagnosis of bacterial overgrowth after culturing small bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol 1992; 27: 253-258
5. Bauer TM, Steinbruckner B, Brinkmann FE et al. Small intestinal bacterial overgrowth and bacterial translocation in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001; 97: 2364-2370
6. Biancone L, Vernia P, Agostini D et al. Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test. Curr Med Res Opin 2000; 16: 14-20
7. Blaut M. Ökologie des Darms. In: Caspary WF, Kist M, Stein J. (Hrsg). Infektiologie des Gastrointestinaltraktes. Springer Verlag Berlin, Heidelberg, New York, 2006: 31-44
8. Bjorneklett A, Fausa O, Midtvedt T. Small bowel bacterial overgrowth in the postgastrectomy syndrome. Scand J Gastroenterol 1983; 18: 277-287
9. Bjorneklett A, Fausa O, Midtvedt T. Bacterial overgrowth in jejunal and ileal disease. Scand J Gastroenterol 1983; 18: 289-298
10. Bouhnik Y, Alain S, Attar A. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94: 1327-1331
11. Brandt LJ, Bernstein LH, Wagle A. Production of vitamin B12 analogues in patients with small-bowel bacterial overgrowth. Ann Intern Med 1977; 87: 546-551
12. Brummer RJ, Armbrecht U, Bosaeus I et al. The hydrogen (H2) breath test. Sampling methods and the influence of dietary fibre on fasting level. Scand J Gastroenterol 1985; 20: 1007-1013
13. Caspary WF, Reimold WV. Klinische Bedeutung des 14C-Glykocholat-Atemtests in der gastroenterologischen Diagnostik bei Erkrankungen mit gesteigerter Dekonjugation von Gallensäuren. Dtsch Med Wschr 1976; 101: 353-360
14. Castiglione F, Rispo A, Di Girolamo E et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1107-1112
15. Chang CS, Chen GH, Lien HC et al. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 1187-1190
16. Chang J, Defilippi C, Defilippi C. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 1187-1190
17. Corazza GR, Menozzi MG, Strocchi A et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98: 302-309
18. Corazza GR, Di Stefano M, Scarpignato C. Treatment of functional bowel disorders: is there room for antibiotics? Digestion 2006; 73 (Suppl 1): 38-46
19. Cuoco L, Montalto M, Jorizzo RA et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology 2002; 49: 1582-1586
20. Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol 2006; 52: 89-95
21. Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig Dis Sci 2005; 50: 758-766
22. Dellert SF, Nowicki MJ, Farrell MK et al. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr 1997; 25: 153-158
23. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel sindrome. Clin Gastroenterol Hepatol 2006; 4: 11-20
24. Di Stefano M, Malservisi S, Veneto G et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000; 14: 551-556
25. Di Stefano M, Miceli E, Missanelli A et al. Absorbable vs. nonabsorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 2005; 21: 985-992
26. Draganov P, Toskes P. Is the prevalence of small bowel bacterial overgrowth in patients with irritable bowel syndrome increased? The question remains unanswered. Dig Dis Sci 2005; 50: 1461
27. Elphick DA, Chew TS, Higham SE. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier? Gerontology 2005; 51: 396-401
28. Falk PG, Hooper LV, Midvedt T et al. Creating and maintaining the gastrointestinal ecosystem: what we know and need to knoe from gnotobiology. Microbiol Mol Biol Rev 1998; 62: 1157-1170
29. Fried M, Siegrist H, Frei R et al. Duodenal bacterial overgowth during treatment in outpatients with omeprazole. Gut 1994; 35: 23-26
30. Ghoshal U, Ghoshal UC, Ranjan P et al. Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol 2003; 3: 9
31. Gianella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology 1974; 80: 965-974
32. Gorbach SL, Nahas L, Lerner PI et al. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 1967; 53: 845-855
33. Gregg CR, Toskes PP. Enteric bacterial flora and small bowel bacterial overgrowth syndrome. In: Feldman M, Scharschmidt BF, Sleisenger MH (Hrsg). Gastrointestinal and liver disease. Philadelphia: W.B. Saunders; 2002: 1783-1793
34. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 27-31
35. Riordan SM, McIver CJ, Wakefield D et al. Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol 1997; 92: 47-51
36. Gunnarsdottir SA, Sadik R, Shev S et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and potal hypertension. Am J Gastroenterol 2003; 98: 1362-1370
37. Hansel S, Lyden E, Gilroy R et al. Prevalence and risk factors of small intestinal bacterial overgrowth in short bowel syndrome. Gastroenterology 2005; 128: A679
38. Hoverstad T, Bjoneklet A, Fausa O et al. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol 1985; 20: 492-499
39. Husebye E, Skar V, Hoverstad T et al. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut 1992; 33: 1331-1337
40. Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med 1995; 237: 419-427
41. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005; 51 (Suppl 1): 1-22
42. Keller J, Franke A, Storr M et al. Klinisch relevante Atemtests in der gastroenterogischen Diagnostik - Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität sowie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Z Gastroenterol 2005; 43: 1071-1090
43. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1998; 95: 982-987
44. King CE, Toskes P. Protein-losing enteropathy in the human and experimental rat blind loop syndrome. Gastroenterology 1981; 80: 504-511
45. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-1189
46. 14C]bile acid breath test in patients with small intestinal bacterial overgrowth. Dig Dis Sci 1980; 25: 53-58
47. Kohler H, McCormick BA, Walker BA. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 2003; 36: 175-185
48. Lauritano EC, Gabrielli M, Lupascu A et al. Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 22: 31-35
49. Lewis SJ, Franco S, Young G et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther 1996; 10: 557-561
50. Li E. Bacterial overgrowth. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW ((Hrsg). Textbook of Gastroenterology. Philadelphia: Lippincott Williams & Wilkins, 1999: 1697-1703
51. Lichtman SN, Keku J, Schwab JH et al. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 1991; 100: 512-519
52. Lin HC. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel disease. JAMA 2004; 292: 852-858
53. Lupascu A, Gabrielli M, Lauritano EC et al. Hydrogene glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 1157-1160
54. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69: 1035S-1045S
55. Madrid AM, Hurtado C, Venegas M et al. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol 2001; 96: 1251-1255
56. McEvoy A, Dutton J, James OFW. Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. BMJ 1983; 287: 789-793
57. Milberg P, Eckardt L, Bruns HJ et al. Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes. J Pharmacol Exp Ther 2002; 303: 218-225
58. Morencos FC, de las Heras Castano G, Martin Ramos L et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995; 40: 1252-1256
59. Morenos FC, De Las Heras Castano G, Meal R. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995; 40: 1252-1256
60. Mowat C, Williams C, Gillen D et al. Helicobacter pylori status and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 2000; 119: 339-347
61. Nayak AK, Karnad DR, Abraham P et al. Metronidazole relieves symptoms in irritable bowel syndrome: the confusion with so-called "chronic amebiasis". Indian J Gastroenterol 1997; 16: 137-139
62. Nieuwenhuijs VB, Verheem A, van Duijvebode-Beumer H et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 1998; 228: 188-193
63. O'Keefe SJ. Bacterial overgrowth and liver complications in short bowel intestinal failure patients. Gastroenterology 2006; 130 (Suppl 1): S67-S69
64. Pardo A, Bartoli R, Lorenzo-Zuniga V et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858-863
65. Pelosini I, Scarpignato C. Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract. Chemotherapy 2005; 51: 122-130
66. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-3506
67. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlated with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 412-419
68. Pimentel M, Soffer E, Chow EJ et al. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci 2002; 47: 2639-2643
69. Pimentel M, Park S, Mirocha J et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006; 145: 557-563
70. Pimentel M, Chatterjee S, Chow EJ et al. Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study. Dig Dis Sci 2006; 51: 1297-301
71. Posserud I, Stotzer PO, Bjornsson E et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2006; [Epub ahead of print]
72. Riordan SM, McIver CJ, Walker BM et al. The lactulose breath tests and small intestinal overgrowth. Am J Gastroenterol 1996; 91: 1795-1799
73. Riordan SM, McIver CJ, Wakefield D et al. Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol 1997; 92: 47-51
74. Riordan SM, McIver CJ, Wakefield D et al. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol 2001; 96: 494-500
75. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely used in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpreatation. Am J Gastroenterol 2002; 97: 1113-1116
76. Rumessen JJ, Gudmand-Hoyer E, Bachmann E et al. Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14C-D-xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol 1985; 20: 1267-1275
77. Sadik R, Abrahamson H, Bjornsson E et al. Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol 2003; 38: 1039-1044
78. Saltzman JR, Kowdley KV, Pedrosa MC et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994; 106: 615-623
79. Sanduleanu S, Jonkers D, De Bruine A et al. Non-helicobacter pylori bacterial flora during acid-suppressive therapy: differential fidings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 2001; 15: 379-388
80. Schmidt T, Pfeiffer A, Kaess H. Abnormal intestinal motility in irritable bowel syndrome. Gastroenterology 1996; 111: 1400-1401
81. Scott LD, Cahall DL. Influence of the interdigestive myoelectric complex on enteric flora in the rat. Gastroenterology 1982; 82: 737-745
82. Sharma BK, Santana IA, Wood EC et al. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J 1984; 289: 717-719
83. Sherman P, Wesley A, Forstner GG. Sequential disacchridase loss in rat intestinal blind loops: impact of malnutrition. Am J Physiol 1985; 248: G626-G632
84. Shindo K, Machida M, Koide K et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology 1998; 45: 1643-1650
85. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55 (3): 297-303
86. Strid H, Simren M, Stotzer PO et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion 2003; 67 (3): 129-137
87. Solomons NW, Schoeller DA, Wagonfeld JB et al. Application of a stable isotope (13C)-labeled glycocholate breath test to the diagnosis of bacterial overgrowth. J Lab Clin Med 1977; 90: 431-439
88. Soudah HC, Hasler Wi, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. New Engl J Med 1991; 325: 1461-1467
89. Stockbruegger RW, Cotton PB et al. Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol 1984; 19: 355-364
90. Stotzer PO, Blomberg L, Conway PL et al. Probiotic treatment of small bacterial overgrowth by Lactobacillus fermentus KLD. Scand J Infect Dis 1996; 28: 615
91. Tabaqchali S, Hatzioannou J, Booth CC. Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet 1968; 2 (7558): 12-16
92. Theisen J, Nehra D, Citron D et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 2000; 4: 50-54
93. Thorens J, Froehlich F, Schwizer W et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996; 39: 54-59
94. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 1999; 15: 47-52
95. Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten with-drawal. Am J Gastroenterol 2003; 98: 839-843
96. van Felius ID, Akkermans LM, Bosscha K et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 2003; 15: 267-276
97. Vanderhoof JA, Young RJ. Probiotic therapy in children with short bowel syndrome and bacterial overgrowth (abstract). Gastroenterology 1997; 112: A916
98. Vanderhoof JA, Young RJ, Murray N et al. Treatment strategies for small bowel bacterial overgrowth. J Pediatr Gastroenterol Nutr 1998; 27: 155-160
99. Verdu EF, Fraser R, Armstrong D et al. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers. Scand J Gastroenterol 1994; 29: 1065-1069
100. Welkos SL, Toskes PP, Baer H et al. Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology 1981; 80: 313-320
101. Wigg AJ, Roberts-Thomson IC, Dymock RB et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206-211
102. Williams C, McColl KEL. Proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther 2005; 23: 3-10
103. Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath test. Scand J Gastroenterol 1998; 33: 867-871